These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6574725)

  • 21. Successful treatment of gram-negative bacillary meningitis with imipenem/cilastatin.
    Rodriguez K; Dickinson GM; Greenman RL
    South Med J; 1985 Jun; 78(6):731-2. PubMed ID: 3859018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cilastatin (MK 0791) is a potent and specific inhibitor of the renal leukotriene D4-dipeptidase.
    Köller M; Brom J; Raulf M; König W
    Biochem Biophys Res Commun; 1985 Sep; 131(2):974-9. PubMed ID: 3863619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients.
    Zajac BA; Fisher MA; Gibson GA; MacGregor RR
    Antimicrob Agents Chemother; 1985 May; 27(5):745-8. PubMed ID: 3860187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Fujimoto H; Ikeda K; Yamamoto K; Taguchi S; Shirakawa K
    Jpn J Antibiot; 1986 Jun; 39(6):1607-11. PubMed ID: 3463801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fundamental study of imipenem/cilastatin sodium in obstetrics and gynecology].
    Taguchi K; Saito Y; Seki H; Murata M; Shidara Y; Sayama T; Sato Y; Isobe K
    Jpn J Antibiot; 1986 Jun; 39(6):1514-8. PubMed ID: 3463792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fundamental and clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Takamura S; Hata T; Kumagaya J; Yamabe T
    Jpn J Antibiot; 1986 Jun; 39(6):1620-5. PubMed ID: 3463803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of N-formimidoyl thienamycin into extravascular fluids in rabbits.
    Olay T; Vicente MV; Rodríguez A
    Chemotherapy; 1986; 32(5):404-7. PubMed ID: 3463447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primaxin in the treatment of acute bacterial pneumonia in adults.
    Gebhart RJ; Duma RJ; Patterson PM; Bagett JW; Williams DS
    J Antimicrob Chemother; 1985 Feb; 15(2):233-8. PubMed ID: 3980311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-Lactamase activity of renal dipeptidase against N-formimidoyl-thienamycin.
    Kim HS; Campbell BJ
    Biochem Biophys Res Commun; 1982 Oct; 108(4):1638-42. PubMed ID: 6983880
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.
    Kropp H; Sundelof JG; Hajdu R; Kahan FM
    Antimicrob Agents Chemother; 1982 Jul; 22(1):62-70. PubMed ID: 7125632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
    Fujii R; Meguro H; Arimasu O; Yoshioka H; Fujita K; Maruyama S; Inyaku F; Nagamatsu I; Wagatsuma Y; Takase A
    Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Chimura T; Morisaki N; Matsuo M
    Jpn J Antibiot; 1986 Jun; 39(6):1519-25. PubMed ID: 3463793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Okamura K; Nakakuki M; Yamada K; Ikeno N; Watanabe M; Takahashi K; Muraguchi K; Saito A; Wakisaka T; Murai H
    Jpn J Antibiot; 1986 Jun; 39(6):1526-30. PubMed ID: 3463794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Horii T; Noda K
    Jpn J Antibiot; 1986 Jun; 39(6):1601-6. PubMed ID: 3463800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
    Verbist L; Verpooten GA; Giuliano RA; Debroe ME; Buntinx AP; Entwistle LA; Jones KH
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():115-20. PubMed ID: 3469184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of the pharmacology of imipenem/cilastatin.
    Drusano GL
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():79-92. PubMed ID: 3546249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
    Horadam VW; Smilack JD; Montgomery CL; Werringloer J
    Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the degradation of imipenem within serum and a renal kidney fraction.
    Köller M; Brom J; Schönfeld W; Knöller J; König W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 May; 261(3):330-7. PubMed ID: 3090805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Ito K; Ito T; Matsunami K; Takada Y; Hayasaki M; Noda K
    Jpn J Antibiot; 1986 Jun; 39(6):1565-82. PubMed ID: 3463797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.